Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review

Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review

Show other versions (1)

<strong>Objectives: </strong>In this paper, we emphasised that effective management of health plans beneficiaries access to reimbursed medicines requires proper institutional set-up. The main objective was to identify and recommend an institutional framework of integrated pharmaceutical...

Full description

Bibliographic Details
Main Authors:	Tomasz Roman Hermanowski, Aleksandra Krystyna Drozdowska, Marta Kowalczyk
Format:	Article
Language:	English
Published:	Ubiquity Press 2015-09-01
Series:	International Journal of Integrated Care
Subjects:	Pharmaceutical Benefits Management Pharmacy Benefit Managers generic substitution generic drugs online adjudication of pharmacy claims e-Prescribing integrated care
Online Access:	http://www.ijic.org/articles/2253

Similar Items

Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review
by: Tomasz Roman Hermanowski, et al.
Published: (2015-09-01)

Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01)

Knowledge and perception of senior year pharmacy students about generic medicines in public Universities of Malaysia
by: Shi Wei Lee, et al.
Published: (2014-01-01)

A Model Comparing Drug Utilization and Pharmaceutical Expenditures in Community and Mail-Order Pharmacy in a Retiree Population
by: Visaria, Jay L.
Published: (2008)

Generic medicine and prescribing: A quick assessment
by: Mainul Haque
Published: (2017-01-01)

Physicians’ Knowledge, Attitude and Practice of Generic Substitution in China: A Cross-Sectional Online Survey
by: Mingyue Zhao, et al.
Published: (2021-07-01)

Extent of Drug Coverage across Generic Drug Discount Programs offered by Community Pharmacies: A look at five Chronic Conditions
by: Harshali K. Patel, et al.
Published: (2012-01-01)

Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland
by: Henriikka Nokelainen, et al.
Published: (2020-02-01)

Generic policy in Bulgaria: a policy of failure or success?
by: Assena Stoimenova, et al.
Published: (2016-09-01)

Are antibiotics substandard in Lebanon? Quantification of active pharmaceutical ingredients between brand and generics of selected antibiotics
by: Eva Hobeika, et al.
Published: (2020-02-01)

Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice
by: Andrea Bakker
Published: (2017-06-01)

Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland
by: Tomasz Hermanowski, et al.
Published: (2013-10-01)

Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland
by: Tomasz Hermanowski, et al.
Published: (2013-10-01)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
by: Epstein RS
Published: (2021-09-01)

The content of patient counseling about interchangeable medicines and generic substitution in Finnish community pharmacies - a survey of dispensers
by: Riikka Rainio, et al.
Published: (2019-12-01)

The adoption of generic drugs by a hospital: effects on drug dispensation among community pharmacies
by: Tomoya Tachi, et al.
Published: (2018-03-01)

Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
by: F. Cankat Tulunay, et al.
Published: (2010-08-01)

LIFE CYCLE OF THE PHARMACEUTICAL PRODUCT AND PRIMARY STRATEGIC GOALS
by: Cristina CIOT
Published: (2015-12-01)

Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database
by: Arnet I, et al.
Published: (2018-09-01)

Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
by: Corbin, Morgan, et al.
Published: (2017)

Drug prescription pattern of outpatients in a tertiary care teaching hospital in Tamil Nadu
by: S Shanmugapriya, et al.
Published: (2018-01-01)

Descriptive Analysis of Acceptance by Prescribers and Economic Benefit of Pharmacist Recommended Interventions in a Critical Care Unit
by: YoonJung Lee, et al.
Published: (2018-07-01)

Advertising Traded Goods
by: Henry W. Kinnucan
Published: (1999-07-01)

Do Farmers Get an Equal Bang for Their Buck from Generic Advertising Programs? A Theoretical and Empirical Analysis
by: Chanjin Chung, et al.
Published: (2000-07-01)

How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
by: Dylst P, et al.
Published: (2012-03-01)

Institutional framework of pharmaceutical benefits management
by: Hermanowski Tomasz, et al.
Published: (2014-10-01)

Institutional framework of pharmaceutical benefits management
by: Hermanowski Tomasz, et al.
Published: (2014-10-01)

Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
by: D. Husselmann, et al.
Published: (2016-12-01)

Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
by: D. Husselmann, et al.
Published: (2016-10-01)

Pharmaceutical interventions on prescriptions in Norwegian community and hospital pharmacies
by: Gangås, I.E.M, et al.
Published: (2021)

State of the Russian pharmaceutical industry at the present stage
by: E. N. Hoseva
Published: (2018-06-01)

Naloxone: The State of Co-Prescribing and Co-Dispensing
by: Hagemeier, Nicholas E.
Published: (2018)

Implementation of aid as pharmaceutical innovation towards national and foreign pharmaceutical practice
by: L. M. Unhurian, et al.
Published: (2017-02-01)

Drug Import Replacement Is a Perspective Direction of the Development of Russian Economy
by: K. D. Grigorieva
Published: (2018-07-01)

Choosing Evolution over Extinction: Integrating Direct Patient Care Services and Value-Based Payment Models into the Community-Based Pharmacy Setting
by: Amanda R. Mercadante, et al.
Published: (2020-07-01)

Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
by: E. A. Ushkalova, et al.
Published: (2018-07-01)

Internet technologies in the provision of pharmaceutical care
by: Lobova E.D., et al.
Published: (2014-06-01)

Representative sample survey on factors determining the Czech physicians’ awareness of generic drugs and substitution
by: J. Maly, et al.
Published: (2019-10-01)

Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study
by: Mattioli F, et al.
Published: (2017-08-01)

Opinions of Czech general practitioners on generic drugs and substitution
by: Dosedel Martin, et al.
Published: (2014-12-01)